 Independent prognostic factors patients metastatic stage prostate cancer Zoladex Study Group independent prognostic factors survival men treatment metastatic prostate cancer part randomized clinical trial gonadotropin hormone analogue Zoladex goserelin acetate implant castration multivariate analysis significant predictors presence absence bone pain testosterone levels serum alkaline phosphatase levels performance status Patients factors favorable survival survival rate patients none factors favorable survival factors significant separate analysis serum testosterone levels pretreatment serum testosterone level survival rate patients serum testosterone levels nmol/L significant differences survival patients serum testosterone levels nmol/L results important implications design analysis future clinical trials hormone therapy patients short-term prognosis disease